It is estimated that around 6.7 million people in the world are suffering from chronic wounds. One in four diabetes patients develop ulceration in the foot, and 70% of these wounds do not get healed because of a mismanaged infection. The traditional ways in which an infected wound is diagnosed is through a culture test, doppler test, CT angiography or biopsy. These are costly, and the report generation takes a few days, depending on where the patient is located. 

Adiuvo Diagnostics’ flagship product – Illuminate – is a rapid, point-of-care, handheld device that diagnoses wound infections and does pathogen classification in significantly less amount of time than traditional methods. Living bacteria have an autofluorescence property; it emits light in response to appropriate stimuli. Illuminate creates multi-spectral images of an infected wound based on the light emitted by the pathogens and assesses the images using AI and deep learning. It is then able to detect and classify the pathogen in less than 2 minutes! This platform technology has wider application beyond wound management to areas such as skin parameter assessment, cancer diagnostics, and water quality assessment.